China Sets Timeline for Reporting to SAEs in Vaccine Clinical Trials

Drug Industry Daily
Sponsors of vaccine trials intended to support a marketing submission in China have seven days to report study-related fatalities and another eight days to file follow up reports, according to a new China Food and Drug Administration guideline.

To View This Article:


Subscribe To Drug Industry Daily